secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardiff Lexington Corp (CDIX)
CIK:        0000811222
Form:       8-K
Filed at:   2026-09-24T11:59:53+00:00
Accession:  0001683168-26-007348
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardiff Lexington signs LOI to acquire musculoskeletal platform for up to $104M
-------------------------------------------------------------------------------

- LOI with owners of multi-location musculoskeletal platform; total purchase price up to $104 million.
- Consideration: $30M cash at close, $10M notes due 2 years, preferred equity = 35% fully diluted, plus $12M stock earnout.
- Earnout: $4M stock each if 2027 EBITDA >$15M, 2028 >$18M, 2029 >$22M.
- Due diligence up to 45 days; target closing date November 16, 2026; financing not yet committed.
- Proposed deal expands orthopedics, spine, pain management; sellers to retain leadership roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811222/000168316826007348/0001683168-26-007348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811222/000168316826007348/cardiff_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-007348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer